Hearing Loss and Osteoporosis

NCT03895333 | Completed

• 1 other identifier: 2019.01.01
• Study Type: observational
• Target: 160
• Locations: 1 country
• Sites: 1

Brief Summary

To compare the audiological profiles in postmenopausal women with and without osteoporosis and to examine the pattern of hearing loss in osteoporotic patients. postmenopausal women will be separated as normal, osteopenic and osteoporotic according to bone mineral densitometry results. The evaluation of hearing test will be done in these groups and the results will be compared between the groups.

Conditions

Hearing Loss; Osteoporosis, Postmenopausal

Keywords

Bone mineral density; Postmenopause

Outcome Measures

Primary Outcomes (2)

• hearing test results

  hearing test results will be examined; Hearing loss result: test passed or test will be recorded as not passed.

  1 week

• bone mineral densitometry measurements

  bone mineral densitometry measurements of patients with hearing test. those with bone loss will be evaluated as osteoporosis.

  1 week

Study Arms (2)

study group

women with hearing loss and osteoporosis will develop the study group.

Other: Audiological profiling and bone mineral densitometry measurement

control group

women who have hearing loss but have no osteoporosis will constitute the control group.

Other: Audiological profiling and bone mineral densitometry measurement

Interventions

Audiological profiling and bone mineral densitometry measurement OTHER

bone mineral densitometry measurements and hearing test patients, osteoporosis according to whether the hearing test will be analyzed.

control group; study group

Eligibility Criteria

• Age: 45 Years - 60 Years
• Sex: female
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Postmenopausal women who had hearing test between the ages of 45-60 formed the study group

You may qualify if:

• Between 45-60 years
• postmenopausal women

You may not qualify if:

• Women over 60 years old,
• acute or chronic otitis media,
• ear surgery,
• use of ototoxic drugs,
• congenital hearing loss,
• previous long-term steroid use,
• malignant or benign neoplasm of the brain,
• Patients with a history of exposure to noise were excluded from the study.

Sponsors & Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital: lead

Study Sites (1)

Kanuni Sultan Süleyman Training and Research Hospital

Istanbul, 33404, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hearing Loss; Osteoporosis, Postmenopausal

Condition Hierarchy (Ancestors)

Hearing Disorders; Ear Diseases; Otorhinolaryngologic Diseases; Sensation Disorders; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Osteoporosis; Bone Diseases, Metabolic; Bone Diseases; Musculoskeletal Diseases; Metabolic Diseases; Nutritional and Metabolic Diseases

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator, M.D, Department of Obstetrics and GynecologyR

Study Record Dates

• First Submitted: March 26, 2019
• First Posted: March 29, 2019
• Study Start: March 1, 2019
• Primary Completion: March 1, 2020
• Study Completion: March 1, 2020
• Last Updated: April 28, 2020

Record last verified: 2020-04

Locations

TU (1)